Company Indiva Limited

NDVA

CA45580J1012

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Alternative Medicine

Delayed Toronto S.E. Other stock markets 16:28:31 01/05/2024 BST			5-day change	1st Jan Change
0.065 ^CAD	-7.14%		-7.14%	-31.58%

04-25	Transcript : Indiva Limited, Q4 2023 Earnings Call, Apr 25, 2024
04-25	Indiva Limited Provides Earnings Guidance for the First Quarter and Fiscal Year 2024	CI

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron, Bhang Chocolate, Indiva Doppio Sandwich Cookies, Indiva 1432 Chocolate, and No Future Gummies and Vapes, as well as other Indiva branded extracts. Its products include edibles and capsules. Its edibles include Vanilla Double -Stuffed Chocolate Cookie, Fudge Double-Stuffed Chocolate Cookie, and Golden Vanilla Double Stuffed Cookie. It sells its cannabis products to consumers in the recreational market in the provinces of Ontario, British Columbia, Alberta, Quebec, Nova Scotia, Saskatchewan, Manitoba, New Brunswick, Prince Edward Island, Newfound.

CAD in Million	2022	Weight	2023	Weight	Delta
Cannabis 100.0 %	34	100.0 %	38	100.0 %	+9.21%

CAD in Million	2022	Weight	2023	Weight	Delta
Canada 100.0 %	34	100.0 %	38	100.0 %	+9.21%

Managers	Title	Age	Since
Carmine Marotta FOU	Founder	-	12/09/79
Jennifer Ann Welsh DFI	Director of Finance/CFO	-	12/12/17
Robert William Carse COO	Chief Operating Officer	-	30/04/19
Anthony Simone IRC	Investor Relations Contact	-	-
Leslie Tomlenovich LAW	General Counsel	-	30/11/21
Sherry Kelly HRO	Human Resources Officer	-	31/07/18
Melissa Kurek PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Rachel Goldman BRD	Director/Board Member	52	15/12/21
James Yersh BRD	Director/Board Member	-	12/12/17
Hugh Sutherland BRD	Director/Board Member	-	12/12/17
John Marotta BRD	Director/Board Member	-	12/12/17
Andre Lafleche BRD	Director/Board Member	-	12/12/17
Carmine Marotta FOU	Founder	-	12/09/79
Liam Wilson BRD	Director/Board Member	33	28/02/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	195,488,563	124,545,610 ( 63.71 %)	0	63.71 %

Name	Equities	%	Valuation
CANOPY GROWTH CORPORATION 19.30 %	35,948,500	19.30 %	2 M $
SNDL INC. 8.558 %	15,938,500	8.558 %	956 310 $
John Marotta 4.811 %	8,961,000	4.811 %	537 660 $
Andre Lafleche 2.729 %	5,082,702	2.729 %	304 962 $
Carmine Marotta 2.342 %	4,362,690	2.342 %	261 761 $
Sung Koo Kang 1.093 %	2,035,028	1.093 %	122 102 $
Hugh Sutherland 0.5071 %	944,444	0.5071 %	56 667 $
Liam Wilson 0.1532 %	285,277	0.1532 %	17 117 $
Jennifer Ann Welsh 0.1508 %	280,782	0.1508 %	16 847 $
James Yersh 0.1366 %	254,444	0.1366 %	15 267 $

Indiva Ltd.

333 Preston Street Suite 710

K1S 5N4, Ottawa

+888-649-6686

http://www.indiva.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Alternative Medicine

	1st Jan change	Capi.
INDIVA LIMITED	-31.58%	9.96M
DONG-E-E-JIAO CO.,LTD.	+39.33%	6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-18.38%	4.35B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.17%	3.18B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.98%	3.16B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.41%	2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+48.74%	1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-4.82%	1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-1.24%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-8.96%	1.6B

Alternative Medicine